The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium.

Eva Obermayr Angelika Reiner Burkhard BrandtElena Ioana BraicuReinthaller AlexanderLiselore LoverixNicole ConcinLinn WoelberSven MahnerJalid SehouliIgnace VergoteRobert Zeillinger

Published in: Cancers (2021)

The two-sided analytical approach revealed CTC subpopulations associated with ovarian cancer progression and may illuminate a potential treatment-related shift in molecular phenotypes. That approach can identify patients who have elevated risk of recurrence and death due to ovarian cancer and who may require risk-adapted treatment strategies.

Keyphrases

circulating tumor cells
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
circulating tumor
single cell
drug induced